Search
Search Constraints
You searched for: Author/Creator Dosoo, DavidLimit your search
- Dosoo, David [remove] 6
- 615.372 2
- Communicable diseases -- Periodicals 2
- Vaccines -- Periodicals 2
- 571.99905 1
- 616.9 1
- 616.905 1
- 616.9362005 1
- AE adverse event -- CI confidence interval -- CS circumsporozoite -- ED50 endpoint dilution 50 -- ELISA enzyme-linked immunosorbent assay -- EPI Expanded Programme on Immunization -- EU ELISA units -- GMC geometric mean concentration -- GMT geometric mean titer -- HBs hepatitis B virus surface antigen -- IU international unit -- MR combined measles-rubella -- pIMD potential immune-mediated disease -- RCC reverse cumulative curve -- RTS, S/AS01 pre-erythrocytic Plasmodium falciparum malaria vaccine -- SAE serious adverse event -- UL upper limit -- WHO World Health Organization -- YF yellow fever 1
- AMA apical membrane protein -- APRIL A proliferation-inducing ligand -- BAFF B-cell-activating factors -- BS blood stage -- CelTOS Cell-Traversal Protein for Ookinetes and Sporozoites -- CHMI controlled human malaria infection -- CSP circumsporozoite protein -- EBA erythrocyte binding antigen -- EXP exported protein -- GST Glutathione S-transferase -- Ig immunoglobulin -- LS liver stage -- LSA liver stage antigen -- MSP merozoite surface protein -- MTI malaria transmission intensity -- NAI naturally acquired immunity -- PE pre-erythrocytic -- qSAT quantitative suspension array assay -- Rh reticulocyte binding protein homologue -- SARS-CoV-2 severe acute respiratory syndrome coronavirus 2 -- SSP sporozoite surface protein -- TACI transmembrane activator and calcium-modulating cyclophilin-ligand interactor -- TGF-β1 transforming growth factor β1 1
- Communicable Diseases -- Periodicals 1